Patents by Inventor Jennifer Tsai

Jennifer Tsai has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7964579
    Abstract: The present invention relates to compositions and methods which enhance the delivery of oligonucleotides and other nucleosidic moieties via topical routes of administration. Preferred compositions include liposomes or penetration enhancers for the delivery of such moieties to dermal and/or epidermal tissue in an animal for investigative, therapeutic or prophylactic purposes.
    Type: Grant
    Filed: August 21, 2009
    Date of Patent: June 21, 2011
    Assignee: Isis Pharmaceuticals, Inc.
    Inventors: Rahul C. Mehta, Gregory E. Hardee, Phillip Dan Cook, David J. Ecker, Yali Jennifer Tsai, Michael V. Templin
  • Publication number: 20090326045
    Abstract: The present invention relates to compositions and methods which enhance the delivery of oligonucleotides and other nucleosidic moieties via topical routes of administration. Preferred compositions include liposomes or penetration enhancers for the delivery of such moieties to dermal and/or epidermal tissue in an animal for investigative, therapeutic or prophylactic purposes.
    Type: Application
    Filed: August 21, 2009
    Publication date: December 31, 2009
    Applicant: Isis Pharmaceuticals, Inc.
    Inventors: Rahul C. Mehta, Gregory E. Hardee, Phillip Dan Cook, David J. Ecker, Yali Jennifer Tsai, Michael V. Templin
  • Patent number: 6841539
    Abstract: The present invention relates to compositions and methods which enhance the delivery of oligonucleotides and other nucleosidic moieties via topical routes of administration. Preferred compositions include liposomes or penetration enhancers for the delivery of such moieties to dermal and/or epidermal tissue in an animal for investigative, therapeutic or prophylactic purposes.
    Type: Grant
    Filed: May 20, 1999
    Date of Patent: January 11, 2005
    Assignee: ISIS Pharmaceuticals, Inc.
    Inventors: Rahul C. Mehta, Gregory E. Hardee, Phillip Dan Cook, David J. Ecker, Yali Jennifer Tsai, Michael V. Templin